Style | Citing Format |
---|---|
MLA | Hosseinidastgerdi H, Pourshanazari AA, Nematbakhsh M. "The Role of Mas Receptor on Renal Hemodynamic Responses to Angiotensin Ii Administration in Chronic Renal Sympathectomized Male and Female Rats." Research in Pharmaceutical Sciences, vol. 18, no. 5, 2023, pp. 489-504. |
APA | Hosseinidastgerdi H, Pourshanazari AA, Nematbakhsh M (2023). The Role of Mas Receptor on Renal Hemodynamic Responses to Angiotensin Ii Administration in Chronic Renal Sympathectomized Male and Female Rats. Research in Pharmaceutical Sciences, 18(5), 489-504. |
Chicago | Hosseinidastgerdi H, Pourshanazari AA, Nematbakhsh M. "The Role of Mas Receptor on Renal Hemodynamic Responses to Angiotensin Ii Administration in Chronic Renal Sympathectomized Male and Female Rats." Research in Pharmaceutical Sciences 18, no. 5 (2023): 489-504. |
Harvard | Hosseinidastgerdi H, Pourshanazari AA, Nematbakhsh M (2023) 'The Role of Mas Receptor on Renal Hemodynamic Responses to Angiotensin Ii Administration in Chronic Renal Sympathectomized Male and Female Rats', Research in Pharmaceutical Sciences, 18(5), pp. 489-504. |
Vancouver | Hosseinidastgerdi H, Pourshanazari AA, Nematbakhsh M. The Role of Mas Receptor on Renal Hemodynamic Responses to Angiotensin Ii Administration in Chronic Renal Sympathectomized Male and Female Rats. Research in Pharmaceutical Sciences. 2023;18(5):489-504. |
BibTex | @article{ author = {Hosseinidastgerdi H and Pourshanazari AA and Nematbakhsh M}, title = {The Role of Mas Receptor on Renal Hemodynamic Responses to Angiotensin Ii Administration in Chronic Renal Sympathectomized Male and Female Rats}, journal = {Research in Pharmaceutical Sciences}, volume = {18}, number = {5}, pages = {489-504}, year = {2023} } |
RIS | TY - JOUR AU - Hosseinidastgerdi H AU - Pourshanazari AA AU - Nematbakhsh M TI - The Role of Mas Receptor on Renal Hemodynamic Responses to Angiotensin Ii Administration in Chronic Renal Sympathectomized Male and Female Rats JO - Research in Pharmaceutical Sciences VL - 18 IS - 5 SP - 489 EP - 504 PY - 2023 ER - |